Ambrx Biopharma Number of Employees 2020-2022 | AMAM

Ambrx Biopharma number of employees from 2020 to 2022. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
Ambrx Biopharma Annual Number of Employees
2021 81
2020 70
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.019B $0.007B
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $171.964B 10.49
GSK (GSK) United Kingdom $71.240B 8.93
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.458B 19.56
Ginkgo Bioworks Holdings (DNA) United States $3.841B 0.00
Myovant Sciences (MYOV) United Kingdom $2.593B 0.00
Arcus Biosciences (RCUS) United States $2.495B 37.46
Biohaven (BHVN) United States $1.127B 0.00
Emergent Biosolutions (EBS) United States $0.589B 4.63
Zymeworks (ZYME) Canada $0.487B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.267B 0.00
Enzo Biochem (ENZ) United States $0.095B 0.00
SQZ Biotechnologies (SQZ) United States $0.052B 0.00
Gelesis Holdings (GLS) United States $0.025B 0.00